8 Best Definitive Healthcare Alternatives & Competitors (2026)

IQVIA offers a broad suite of real-world data, analytics and technology solutions used by pharma and life sciences companies for clinical research, commercial targeting and provider insights. Its strength lies in massive claims and prescription datasets plus consulting services, giving it wider global coverage than H1 in some therapeutic areas. However, IQVIA tends to be more expensive and less focused on unified MDM or rapid roster automation for health plans compared with H1's specialized provider and site universes.

Doximity is the largest professional network for US physicians and offers digital marketing, recruitment and telehealth tools. Life sciences teams sometimes use its verified HCP profiles for outreach, yet it lacks H1's structured clinical trial site data, performance benchmarks and MDM capabilities. Doximity is generally lower cost for basic access but not positioned as an enterprise data platform.

Veeva provides cloud software for life sciences including CRM, clinical operations and data management platforms that many pharma teams already use. Its Vault and Network products help with HCP engagement and trial workflows, offering tighter integration with existing Veeva stacks than H1. While Veeva has strong commercial tools, it relies more on customer-supplied data and offers less standalone real-world provider intelligence than H1's pre-built universes and streams.

Komodo Health builds software and real-world data platforms that map patient journeys and HCP influence using claims and encounter data. It excels at longitudinal patient insights and rare disease tracking, areas where H1 is lighter. Komodo's pricing is also enterprise-oriented but its focus is narrower on patient-centric analytics rather than H1's combined site selection, KOL identification and health-plan roster tools.

Symphony Health, part of ICON, delivers prescription and medical claims data plus analytics for pharma commercial teams. It is strong in prescriber profiling and market access insights, overlapping with H1's Prescriber Universe. Symphony tends to emphasize syndicated reports over the customizable MDM and real-time intelligence streams that H1 promotes for both clinical and payer use cases.

TriNetX operates a global health research network that gives life sciences companies access to de-identified EHR data for protocol design and site feasibility. It is particularly useful for early trial planning and patient count estimates, complementing or replacing parts of H1's clinical solutions. TriNetX is lighter on commercial HCP engagement and health-plan provider data management features than H1.

Healthgrades provides physician and hospital quality data plus patient experience metrics widely used by health systems and digital health companies. Its strength is consumer-facing reputation and referral tools rather than the deep clinical trial or commercial targeting datasets H1 offers to pharma and payers. Pricing is more accessible for smaller organizations but coverage depth is narrower.